PCAS specialises in the development and production of complex molecules for Life Sciences and Innovative Technologies. With 7% of its turnover dedicated to R&D and a wide international presence, PCAS is the preferred industrial partner of market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments, and also includes two subsidiaries with very strong potential: Prot_us in biotechnology and Enersens in high-performance insulation. With a particularly high standard of performance, PCAS achieved net sales of ó179 million in 2015 and employs nearly 900 people in six countries.